193 related articles for article (PubMed ID: 32708274)
1. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.
Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274
[TBL] [Abstract][Full Text] [Related]
2. Separation of plasma-derived exosomes into CD3
Theodoraki MN; Hoffmann TK; Whiteside TL
Clin Exp Immunol; 2018 Jun; 192(3):271-283. PubMed ID: 29431869
[TBL] [Abstract][Full Text] [Related]
3. Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer.
Hofmann L; Medyany V; Ezić J; Lotfi R; Niesler B; Röth R; Engelhardt D; Laban S; Schuler PJ; Hoffmann TK; Brunner C; Jackson EK; Theodoraki MN
Front Med (Lausanne); 2022; 9():904295. PubMed ID: 35899209
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.
Muller L; Mitsuhashi M; Simms P; Gooding WE; Whiteside TL
Sci Rep; 2016 Feb; 6():20254. PubMed ID: 26842680
[TBL] [Abstract][Full Text] [Related]
5. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
[TBL] [Abstract][Full Text] [Related]
6. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
Theodoraki MN; Yerneni S; Gooding WE; Ohr J; Clump DA; Bauman JE; Ferris RL; Whiteside TL
Oncoimmunology; 2019; 8(7):1593805. PubMed ID: 31143513
[No Abstract] [Full Text] [Related]
7. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.
Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL
Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863
[TBL] [Abstract][Full Text] [Related]
8. Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms.
Muller L; Simms P; Hong CS; Nishimura MI; Jackson EK; Watkins SC; Whiteside TL
Oncoimmunology; 2017; 6(8):e1261243. PubMed ID: 28919985
[TBL] [Abstract][Full Text] [Related]
9. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
[TBL] [Abstract][Full Text] [Related]
10. Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP.
Coray M; Göldi V; Schmid L; Benecke L; Figueiró F; Muller L
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430925
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology.
Whiteside TL; Diergaarde B; Hong CS
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207762
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of PD-L1
Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
[TBL] [Abstract][Full Text] [Related]
13. Signaling of Tumor-Derived sEV Impacts Melanoma Progression.
Zebrowska A; Widlak P; Whiteside T; Pietrowska M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709086
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.
Ludwig S; Floros T; Theodoraki MN; Hong CS; Jackson EK; Lang S; Whiteside TL
Clin Cancer Res; 2017 Aug; 23(16):4843-4854. PubMed ID: 28400428
[No Abstract] [Full Text] [Related]
15. Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
Ludwig N; Gillespie DG; Reichert TE; Jackson EK; Whiteside TL
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560461
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived exosomes promote angiogenesis via adenosine A
Ludwig N; Yerneni SS; Azambuja JH; Gillespie DG; Menshikova EV; Jackson EK; Whiteside TL
Angiogenesis; 2020 Nov; 23(4):599-610. PubMed ID: 32419057
[TBL] [Abstract][Full Text] [Related]
17. [Exosomes: potential liquid biopsy in head and neck cancer].
Theodoraki MN; Ludwig S
HNO; 2020 Feb; 68(2):106-110. PubMed ID: 31915880
[TBL] [Abstract][Full Text] [Related]
18. Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression.
Whiteside TL
Adv Exp Med Biol; 2017; 1036():81-89. PubMed ID: 29275466
[TBL] [Abstract][Full Text] [Related]
19. Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8⁺ cell-derived exosomes.
Nazimek K; Ptak W; Nowak B; Ptak M; Askenase PW; Bryniarski K
Immunology; 2015 Sep; 146(1):23-32. PubMed ID: 25808106
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
